{"id":863,"date":"2025-11-02T21:38:00","date_gmt":"2025-11-02T13:38:00","guid":{"rendered":"https:\/\/wingor.abvnet.com\/%e8%8c%b5%e5%86%a0%e7%94%9f%e7%89%a9%e6%8a%a5%e5%91%8a%e5%88%86%e4%ba%ab%e3%80%8a%e7%bb%86%e8%83%9e%e6%b2%bb%e7%96%97%e7%9a%84%e5%95%86%e4%b8%9a%e5%8c%96%e8%b7%af%e5%be%84%e6%8e%a2%e7%b4%a2%ef%bc%9a\/"},"modified":"2026-05-25T10:06:41","modified_gmt":"2026-05-25T02:06:41","slug":"%e8%8c%b5%e5%86%a0%e7%94%9f%e7%89%a9%e6%8a%a5%e5%91%8a%e5%88%86%e4%ba%ab%e3%80%8a%e7%bb%86%e8%83%9e%e6%b2%bb%e7%96%97%e7%9a%84%e5%95%86%e4%b8%9a%e5%8c%96%e8%b7%af%e5%be%84%e6%8e%a2%e7%b4%a2%ef%bc%9a","status":"publish","type":"post","link":"https:\/\/wingor.abvnet.com\/en\/news\/%e8%8c%b5%e5%86%a0%e7%94%9f%e7%89%a9%e6%8a%a5%e5%91%8a%e5%88%86%e4%ba%ab%e3%80%8a%e7%bb%86%e8%83%9e%e6%b2%bb%e7%96%97%e7%9a%84%e5%95%86%e4%b8%9a%e5%8c%96%e8%b7%af%e5%be%84%e6%8e%a2%e7%b4%a2%ef%bc%9a\/","title":{"rendered":"Inglos Biopharma presents "Exploring the Commercialization Path of Cell Therapy: Drugs vs. New Biomedical Technologies" | 2025 Hainan Cell Therapy Conference"},"content":{"rendered":"
<\/p>\n
\"\u56fe\u7247\"<\/span><\/span><\/section>\n
<\/section>\n
2025\u5e7411\u67081-3\u65e5\uff0c\u4ee5\"\u64ce\u9886\u7ec6\u80de\u79d1\u6280\u65b0\u822a\u5411\uff0c\u6784\u7b51\u4ea7\u4e1a\u53d1\u5c55\u65b0\u84dd\u56fe\"\u4e3a\u4e3b\u9898\u7684<\/span>\"\u7ec6\u80de\u5e74\u4f1a\u00b72025\u5e74\u5ea6\u76db\u5178\"\u5728\u6d77\u5357\u535a\u9ccc\u4e50\u57ce\u6c38\u4e0d\u843d\u5e55\u56fd\u9645\u521b\u65b0\u836f\u68b0\u5c55\u9686\u91cd\u4e3e\u884c<\/span>\u3002<\/span><\/span>\u6070\u9022\u8fd1\u671f\uff0c<\/span><\/span>\u56fd\u52a1\u9662\u4ee4\uff08\u7b2c818\u53f7\uff09\u53d1\u5e03<\/span><\/span>\u300a\u751f<\/span><\/span>\u7269\u533b\u5b66\u65b0\u6280\u672f\u4e34\u5e8a\u7814\u7a76\u548c\u4e34\u5e8a\u8f6c\u5316\u5e94\u7528\u7ba1\u7406\u6761\u4f8b\u300b\u5c06\u4e8e<\/span><\/span>2026\u5e745\u67081\u65e5\u6b63\u5f0f\u65bd\u884c<\/span><\/span>\uff0c\u9996\u6b21\u4ece\u56fd\u5bb6\u6cd5\u89c4\u5c42\u9762\uff0c\u4e3a\u957f\u671f\u56f0\u6270\u4ea7\u4e1a\u754c\u7684\u201c\u7814\u7a76\u6210\u679c\u5982\u4f55\u5408\u6cd5\u8d70\u5411\u4e34\u5e8a\u6536\u8d39\u5e94\u7528\u201d\u95ee\u9898\uff0c\u5f00\u8f9f\u4e86<\/span><\/span>\u72ec\u7acb\u4e8e\u836f\u54c1\u5ba1\u6279\u7684\"\u533b\u7597\u6280\u672f\u8f6c\u5316\u8def\u5f84\"\u3002<\/span><\/span>
<\/span><\/span><\/section>\n
11\u67081\u65e5\uff0c<\/span>\u8335\u51a0\u751f\u7269\u5e38\u52a1\u603b\u88c1\u674e\u65af\u971e\u5728\u5927\u4f1a\u4e0a\u53d1<\/span><\/span>\u8868\u300a\u7ec6\u80de\u6cbb\u7597\u7684\u5546\u4e1a\u5316\u8def\u5f84\u63a2\u7d22\uff1a\u836f\u54c1VS\u751f\u7269\u533b\u5b66\u65b0\u6280\u672f\u300b<\/span>\u4e3b\u9898\u62a5\u544a\uff0c\u4ece\u653f\u7b56\u673a\u9047\u4e0e\u4f01\u4e1a\u5b9e\u8df5\u53cc\u7ef4\u5ea6\uff0c\u6df1\u5165\u89e3\u6790\u4e86\u7ec6\u80de\u6cbb\u7597\u7684\u5546\u4e1a\u5316\u521b\u65b0\u8def\u5f84\u3002<\/span><\/span><\/span><\/span><\/section>\n
<\/section>\n
\u674e\u65af\u971e\u5728\u62a5\u544a\u4e2d\u6307\u51fa\uff0c\u300a\u6761\u4f8b\u300b\u89c4\u5b9a\u4e34\u5e8a\u7814\u7a76\u5b9e\u884c\u5907\u6848\u5236\uff0c\u8f6c\u5316\u5e94\u7528\u5b9e\u884c\u5ba1\u6279\u5236\uff0c\u660e\u786e\u8f6c\u5316\u6761\u4ef6\u5e76\u8d4b\u4e88\u5408\u6cd5\u6536\u8d39<\/span><\/span><\/span><\/span>\u6743\u3002<\/span><\/span>\u6b64\u524d\uff0c<\/span><\/span><\/span>\u6d77\u5357\u4e50\u57ce\u5148\u884c\u533a\u7387\u5148\u516c\u5e03\u7ec6\u80de\u6cbb\u7597\u6536\u8d39\u9879\u76ee\u6e05\u5355\uff0c\u6210\u90fd\u3001\u6e56\u5357\u3001\u79e6\u7687\u5c9b\u7b49\u5730\u4e5f\u63a8\u51fa\u76f8\u5e94\u653f<\/span><\/span>\u7b56<\/span><\/span>\u3002<\/span><\/span><\/span><\/span>
<\/span><\/span><\/span><\/section>\n
\u968f\u77402026\u5e745\u6708\u300a\u6761\u4f8b\u300b\u6b63\u5f0f\u5b9e\u65bd\uff0c\u4e2d\u56fd\u7ec6\u80de\u6cbb\u7597\u4ea7\u4e1a\u5c06\u8fdb\u5165\u65b0\u7684\u53d1\u5c55\u9636\u6bb5\u3002\u836f\u54c1\u8def\u5f84\u5c06\u7ee7\u7eed\u63a8\u52a8\u9ad8\u6c34\u5e73\u5faa\u8bc1\u533b\u5b66\u8bc1\u636e\u79ef\u7d2f\uff0c\u65b0\u6280\u672f\u8def\u5f84\u5219\u5c06\u4fc3\u8fdb\u4e34\u5e8a\u6025\u9700\u6280\u672f\u7684\u5feb\u901f\u53ef\u53ca\u3002<\/span><\/span><\/span><\/span><\/section>\n
<\/section>\n
\u4f5c\u4e3a\u4e13\u6ce8\u7ec6\u80de\u6cbb\u7597\u9886\u57df\u7684\u521b\u65b0\u751f\u7269\u533b\u836f\u4f01\u4e1a\uff0c\u8335\u51a0\u751f\u7269\u5728\u836f\u54c1\u4e0e\u751f\u7269\u533b\u836f\u65b0\u6280\u672f\u53cc\u8def\u5f84\u4e0a\u5747\u53d6\u5f97\u91cd\u8981\u8fdb\u5c55\u3002\u516c\u53f8\u4f9d\u6258\u5e72\u7ec6\u80de\u3001\u514d\u75ab\u7ec6\u80de\u3001\u5916\u6ccc\u4f53\u548c\u57fa\u56e0\u5de5\u7a0b\u56db\u5927\u6280\u672f\u5e73\u53f0\uff0c\u5efa\u7acb\u4e86\u8986\u76d6\"\u7814\u53d1-\u751f\u4ea7-\u4e34\u5e8a\"\u7684\u5b8c\u6574\u4ea7\u4e1a\u94fe\u4f53\u7cfb\u3002<\/span><\/span><\/span><\/span><\/section>\n
\u5728\u836f\u54c1\u6ce8\u518c\u8def\u5f84\u4e0a\uff0c\u516c\u53f8\u5df2\u6709<\/span><\/span>4\u6b3e\u5e72\u7ec6\u80de\u836f\u7269IND\u53d7\u7406\u3002<\/span><\/span><\/span>\u6838\u5fc3\u4ea7\u54c1WG103\u4eba\u8110\u5e26\u95f4\u5145\u8d28\u5e72\u7ec6\u80de\u6ce8\u5c04\u6db2\u6cbb\u7597\u6025\u6027\u7f3a\u8840\u6027\u5352\u4e2d\u7684I\u671f\u4e34\u5e8a\u8bd5\u9a8c\uff08\u76f2\u6001\uff09\u9636\u6bb5\u6027\u6570\u636e\u5206\u6790<\/span><\/span>\u663e\u793a\u79ef\u6781<\/span><\/span>\u6210\u679c\uff0c<\/span><\/span>\u76ee\u524d\u7531\u5317\u4eac\u5929\u575b\u533b\u9662\u738b\u62e5\u519b\u9662\u957f\u9886\u8854\uff0c\u8054\u5408\u591a\u5bb6\u56fd\u5bb6\u7ea7\u5352\u4e2d\u4e2d\u5fc3\u5171\u540c\u63a8<\/span><\/span><\/span>\u8fdbII\u671f\u4e34\u5e8a\u8bd5\u9a8c\u3002<\/span><\/span><\/span><\/section>\n
\u5728\u751f\u7269\u533b\u5b66\u65b0\u6280\u672f\u8def\u5f84\u4e0a\uff0c\u516c\u53f8\u524d\u77bb\u6027\u5730\u5e03\u5c40\u5168\u56fd\u4e34\u5e8a\u7814\u7a76\u7f51\u7edc\uff0c\u4e0e70\u4f59\u5bb6\u4e09\u7532\u533b\u9662\u5efa\u7acb\u6df1\u5ea6\u5408\u4f5c\u3002\u4ee5\"WG10X\"\u4e3a\u4ee3\u53f7\u7684\u5e72\u7ec6\u80de\u7cfb\u5217\u7814\u53d1\u7ba1\u7ebf\u591a\u70b9\u5f00\u82b1\uff1aWG106\u6cbb\u7597\u6162\u52a0\u6025\u6027\u809d\u8870\u7aed\u9879\u76ee\u662f\"\u5341\u56db\u4e94\"\u56fd\u5bb6\u91cd\u70b9\u8bfe\u9898\uff0c\u7531\u738b\u798f\u751f\u9662\u58eb\u56e2\u961f\u9886\u8854\uff1bWG107\u6cbb\u7597\u6e83\u75a1\u6027\u7ed3\u80a0\u708e\u9879\u76ee\u5b8c\u6210\u5e7f\u897f\u9996\u4e2a\"\u673a\u6784+\u9879\u76ee\"\u53cc\u5907\u6848\uff1bWG109\u6cbb\u7597\u6025\u6027\u547c\u5438\u7a98\u8feb\u7efc\u5408\u5f81\u9879\u76ee\u4e5f\u6b63\u5728\u5f00\u5c55\u4e34\u5e8a\u7814\u7a76\u3002\u540c\u65f6\uff0c\u516c\u53f8\u540c\u6b65\u63a8\u8fdb<\/span><\/span>\u591a\u5143\u5316\u6280\u672f<\/span><\/span>\u8def\u5f84\uff0c\u8054\u5408\u5e38\u5dde\u5e02\u7b2c\u4e00\u4eba\u6c11\u533b\u9662\u5f00\u5c55\"W-iNKT\u7ec6\u80de\u8f85\u52a9\u6cbb\u7597\u6d88\u5316\u9053\u80bf\u7624\u4e34\u5e8a\u7814\u7a76\"<\/span><\/span>\u7b49\u3002<\/span><\/span><\/strong><\/strong><\/span><\/span><\/span><\/span><\/section>\n
<\/section>\n
\u674e\u65af\u971e\u6307\u51fa\uff0c\u65e0\u8bba\u9009\u62e9\u54ea\u79cd\u8def\u5f84\uff0c\u8d28\u91cf\u63a7\u5236\u90fd\u662f\u7ec6\u80de\u6cbb\u7597\u5b89\u5168\u6709\u6548\u7684\u57fa\u77f3\u3002\u8335\u51a0\u751f\u7269\u5efa\u7acb\u4e86\u9ad8\u4e8e\u56fd\u9645\u6807\u51c6\u7684\u8d28\u91cf\u7ba1\u7406\u4f53\u7cfb\uff0c\u6bcf\u6279\u6b21\u4ea7\u54c1\u6db5\u76d6600+\u8d28\u91cf\u7ba1\u7406\u6807\u51c6\u3001800+\u8d28\u91cf\u63a7\u5236\u70b9\u30011000+\u8d28\u91cf\u68c0\u6d4b\u8bb0\u5f55\u3002\u5c24\u5176\u5728MSC\u4ea7\u54c1\u5236\u5907\u4e2d\uff0c\u4ece\u4f9b\u4f53\u7b5b\u67e5\u5230\u5236\u5242\u5236\u5907\u7684\u5168\u6d41\u7a0b\u5747\u5b9e\u884c\u4e25\u683c\u8d28\u63a7\uff0c\u786e\u4fdd\u7ec6\u80de\u5b89\u5168\u6027\u3001\u7eaf\u5ea6\u53ca\u751f\u7269\u5b66\u529f\u80fd\u3002\u516c\u53f8<\/span><\/span><\/strong><\/strong><\/span>\u7533\u8bf7<\/span><\/span>\u8fd170\u9879\u4e13\u5229\u4fdd\u62a4\uff0c<\/span><\/span>\u53c2\u4e0e\u5236\u5b9a5\u9879\u884c\u4e1a\u6807\u51c6\uff0c\u4e3a\u53cc\u8def\u5f84\u53d1\u5c55\u63d0\u4f9b\u6280\u672f\u652f\u6491\u3002<\/span><\/span>\u8fd9\u79cd\u5bf9\u8d28\u91cf\u7684\u4e25\u683c\u628a\u63a7\uff0c\u786e\u4fdd\u4e86\u516c\u53f8\u5728\u6280\u672f\u521b\u65b0\u540c\u65f6\u7684\u4ea7\u54c1\u5b89\u5168\u53ef\u9760\u3002<\/span><\/span><\/span><\/section>\n
\u672c\u6b21\u7ec6\u80de\u5e74\u4f1a\u6210\u529f\u8fde\u63a5\u653f\u5e9c\u3001\u4ea7\u5b66\u7814\u4e0e\u533b\u7597\u5404\u65b9\u3002<\/span><\/span>\u7acb\u8db3\u7ec6\u80de\u6cbb\u7597\u4ea7\u4e1a\u53d1\u5c55\u7684\u65b0\u8d77\u70b9\uff0c\u8335\u51a0\u751f\u7269<\/span><\/span>\u5c06<\/span><\/span>\u575a\u5b9a\u63a8\u8fdb\u836f\u54c1\u4e0e\u65b0\u6280\u672f\u53cc\u8def\u5f84\u6218\u7565\uff0c<\/span><\/span>\u7ee7\u7eed\u6df1\u5316\u5728\u8111\u5352\u4e2d\u3001\u809d\u8870\u7aed\u3001\u5375\u5de2\u65e9\u8870\u7b49\u91cd\u5927\u75be\u75c5\u9886\u57df\u7684\u7814\u53d1\u5e03\u5c40\uff0c\u671f\u5f85\u4e0e<\/span><\/span>\u5404\u65b9\u5408\u4f5c\u4f19\u4f34\u643a\u624b\uff0c\u5171\u540c<\/span><\/span>\u5c06\u66f4\u591a\u6280\u672f\u6210\u679c\u8f6c\u5316\u4e3a\u5b88\u62a4\u60a3\u8005\u5065\u5eb7\u7684\u4e34\u5e8a\u529b\u91cf\u3002<\/span><\/span><\/span><\/section>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

2025\u5e7411\u67081-3\u65e5\uff0c\u4ee5\"\u64ce\u9886\u7ec6\u80de\u79d1\u6280\u65b0\u822a\u5411\uff0c\u6784\u7b51\u4ea7\u4e1a\u53d1\u5c55\u65b0\u84dd\u56fe\"\u4e3a\u4e3b\u9898\u7684\"\u7ec6\u80de\u5e74\u4f1a\u00b72025\u5e74\u5ea6\u76db\u5178\"\u5728… Read More »Inglos Biopharma presents "Exploring the Commercialization Path of Cell Therapy: Drugs vs. New Biomedical Technologies" | 2025 Hainan Cell Therapy Conference<\/span><\/a><\/p>","protected":false},"author":1,"featured_media":2031,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"off","neve_meta_content_width":70,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","footnotes":""},"categories":[37],"tags":[],"class_list":["post-863","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gsdt"],"desktop_mode_lock":null,"desktop_mode_contributors":[],"_links":{"self":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/posts\/863","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/comments?post=863"}],"version-history":[{"count":0,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/posts\/863\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/media\/2031"}],"wp:attachment":[{"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/media?parent=863"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/categories?post=863"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/wingor.abvnet.com\/en\/wp-json\/wp\/v2\/tags?post=863"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}